title: Silica-based mesoporous nanoparticles for controlled drug delivery.
abstract: Drug molecules with lack of specificity and solubility lead patients to take high doses of the drug to achieve sufficient therapeutic effects. This is a leading cause of adverse drug reactions, particularly for drugs with narrow therapeutic window or cytotoxic chemotherapeutics. To address these problems, there are various functional biocompatible drug carriers available in the market, which can deliver therapeutic agents to the target site in a controlled manner. Among the carriers developed thus far, mesoporous materials emerged as a promising candidate that can deliver a variety of drug molecules in a controllable and sustainable manner. In particular, mesoporous silica nanoparticles are widely used as a delivery reagent because silica possesses favourable chemical properties, thermal stability and biocompatibility. Currently, sol-gel-derived mesoporous silica nanoparticles in soft conditions are of main interest due to simplicity in production and modification and the capacity to maintain function of bioactive agents. The unique mesoporous structure of silica facilitates effective loading of drugs and their subsequent controlled release. The properties of mesopores, including pore size and porosity as well as the surface properties, can be altered depending on additives used to fabricate mesoporous silica nanoparticles. Active surface enables functionalisation to modify surface properties and link therapeutic molecules. The tuneable mesopore structure and modifiable surface of mesoporous silica nanoparticle allow incorporation of various classes of drug molecules and controlled delivery to the target sites. This review aims to present the state of knowledge of currently available drug delivery system and identify properties of an ideal drug carrier for specific application, focusing on mesoporous silica nanoparticles.
authors.affiliation: Faculty of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
authors.forename: Sooyeon
authors.initials: S
authors.lastname: Kwon
authors.forename: Rajendra K
authors.initials: RK
authors.lastname: Singh
authors.forename: Roman A
authors.initials: RA
authors.lastname: Perez
authors.forename: Ensanya A
authors.initials: EA
authors.lastname: Abou Neel
authors.forename: Hae-Won
authors.initials: HW
authors.lastname: Kim
authors.forename: Wojciech
authors.initials: W
authors.lastname: Chrzanowski
keywords: Mesoporous silica nanoparticle; chemotherapy; controlled release; sol-gel process; targeted drug delivery
references.citation: J Colloid Interface Sci. 2005 Jul 15;287(2):373-8
references.pmid: 15925600
references.citation: Pharmacol Rev. 2004 Jun;56(2):163-84
references.pmid: 15169926
references.citation: Nanotechnology. 2011 Jul 8;22(27):275103
references.pmid: 21613679
references.citation: Nat Rev Drug Discov. 2003 May;2(5):347-60
references.pmid: 12750738
references.citation: Nanotechnology. 2009 Feb 4;20(5):055106
references.pmid: 19417337
references.citation: Int J Nanomedicine. 2013;8:147-58
references.pmid: 23326190
references.citation: J Control Release. 2001 Jun 15;73(2-3):121-36
references.pmid: 11516493
references.citation: J Colloid Interface Sci. 2005 May 15;285(2):574-80
references.pmid: 15837474
references.citation: Adv Drug Deliv Rev. 2003 Feb 24;55(3):329-47
references.pmid: 12628320
references.citation: Acta Pharm. 2005 Mar;55(1):1-25
references.pmid: 15907221
references.citation: J Colloid Interface Sci. 2012 May 15;374(1):45-53
references.pmid: 22364711
references.citation: Small. 2012 Dec 7;8(23):3579-83
references.pmid: 22911545
references.citation: Angew Chem Int Ed Engl. 2011 Jan 24;50(4):882-6
references.pmid: 21246683
references.citation: Biomaterials. 2006 Apr;27(11):2450-67
references.pmid: 16337266
references.citation: Small. 2010 Sep 20;6(18):1952-67
references.pmid: 20690133
references.citation: Cancer Res. 2009 Nov 15;69(22):8784-9
references.pmid: 19887611
references.citation: Small. 2007 Aug;3(8):1341-6
references.pmid: 17566138
references.citation: Int J Nanomedicine. 2012;7:235-42
references.pmid: 22275838
references.citation: Free Radic Res. 2004 May;38(5):439-47
references.pmid: 15293551
references.citation: J Am Chem Soc. 2006 Jun 28;128(25):8116-7
references.pmid: 16787058
references.citation: Chem Commun (Camb). 2008 Jun 21;(23):2662-4
references.pmid: 18535700
references.citation: Angew Chem Int Ed Engl. 2011 Nov 18;50(47):11172-5
references.pmid: 21953879
references.citation: Adv Drug Deliv Rev. 2008 Aug 17;60(11):1278-88
references.pmid: 18514969
references.citation: Small. 2009 Jun;5(12):1408-13
references.pmid: 19296554
references.citation: Cancer Res. 1992 Apr 15;52(8):2346-8
references.pmid: 1559237
references.citation: Expert Opin Drug Deliv. 2009 Dec;6(12):1363-81
references.pmid: 19860534
references.citation: Biomaterials. 2009 Feb;30(5):850-8
references.pmid: 19010531
references.citation: Proc Natl Acad Sci U S A. 1988 Sep;85(18):6949-53
references.pmid: 3413128
references.citation: Chem Rev. 2007 Jul;107(7):2821-60
references.pmid: 17580976
references.citation: J Liposome Res. 2008;18(3):249-62
references.pmid: 18770074
references.citation: Pharm Res. 2001 Apr;18(4):548-50
references.pmid: 11451045
references.citation: Angew Chem Int Ed Engl. 2011 Jan 17;50(3):640-3
references.pmid: 21226142
references.citation: Br J Clin Pharmacol. 2007 Feb;63(2):163-70
references.pmid: 17274789
references.citation: Cancer Causes Control. 2004 Sep;15(7):697-706
references.pmid: 15280628
references.citation: Br J Clin Pharmacol. 2012 Jun;73(6):912-6
references.pmid: 22360355
references.citation: Chem Commun (Camb). 2003 Sep 21;(18):2364-5
references.pmid: 14518916
references.citation: Adv Drug Deliv Rev. 2002 Oct 16;54(7):963-86
references.pmid: 12384317
references.citation: J Am Chem Soc. 2009 Oct 28;131(42):15136-42
references.pmid: 19799420
references.citation: Philos Trans A Math Phys Eng Sci. 2012 Mar 28;370(1963):1400-21
references.pmid: 22349248
references.citation: Int J Mol Sci. 2011;12(7):4395-413
references.pmid: 21845085
references.citation: Adv Drug Deliv Rev. 2002 Oct 16;54(7):911-31
references.pmid: 12384315
references.citation: Adv Drug Deliv Rev. 2008 May 22;60(8):939-54
references.pmid: 18343527
references.citation: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 May-Jun;2(3):249-59
references.pmid: 20166124
references.citation: Curr Opin Biotechnol. 1995 Dec;6(6):698-708
references.pmid: 8527843
references.citation: Mater Sci Eng C Mater Biol Appl. 2013 Aug 1;33(6):3426-31
references.pmid: 23706230
references.citation: J Am Chem Soc. 2004 Jan 21;126(2):462-3
references.pmid: 14719932
references.citation: Chem Commun (Camb). 2009 Sep 14;(34):5094-6
references.pmid: 20448957
references.citation: Angew Chem Int Ed Engl. 2007;46(40):7548-58
references.pmid: 17854012
references.citation: ChemMedChem. 2008 Jan;3(1):20-53
references.pmid: 17963208
references.citation: J Am Chem Soc. 2010 Sep 15;132(36):12690-7
references.pmid: 20718462
references.citation: Nanotechnology. 2011 May 20;22(20):205702
references.pmid: 21444966
references.citation: Acc Chem Res. 2007 Sep;40(9):846-53
references.pmid: 17645305
references.citation: ACS Nano. 2010 Nov 23;4(11):6353-68
references.pmid: 20958020
references.citation: J Am Chem Soc. 2011 Jan 19;133(2):172-5
references.pmid: 21158438
references.citation: J Am Chem Soc. 2011 Dec 14;133(49):19582-5
references.pmid: 21981330
references.citation: ACS Nano. 2008 May;2(5):889-96
references.pmid: 19206485
references.citation: J Am Ceram Soc. 2009 Jan 1;92(s1):s2-s10
references.pmid: 19834571
references.citation: Biomaterials. 2010 Apr;31(12):3335-46
references.pmid: 20106517
references.citation: Expert Opin Biol Ther. 2003 Aug;3(5):745-58
references.pmid: 12880375
references.citation: Biomaterials. 2013 Mar;34(10):2565-75
references.pmid: 23332175
references.citation: Chem Commun (Camb). 2011 Jan 7;47(1):532-4
references.pmid: 21082109
references.citation: J Am Chem Soc. 2009 Apr 1;131(12):4230-2
references.pmid: 19317500
references.citation: J Biomed Mater Res. 1999 Oct;47(1):104-10
references.pmid: 10400888
references.citation: Antimicrob Agents Chemother. 2008 Apr;52(4):1330-6
references.pmid: 18227177
references.citation: Chem Commun (Camb). 2011 Sep 14;47(34):9572-87
references.pmid: 21655634
references.citation: J Antimicrob Chemother. 1994 Feb;33(2):273-9
references.pmid: 8182008
references.citation: Biomaterials. 2000 Dec;21(23):2475-90
references.pmid: 11055295
references.citation: J Am Chem Soc. 2003 Apr 16;125(15):4451-9
references.pmid: 12683815
references.citation: Photochem Photobiol. 2010 Jul-Aug;86(4):964-71
references.pmid: 20492566
references.citation: Nanotechnology. 2011 Nov 11;22(45):455102
references.pmid: 22019849
references.citation: Angew Chem Int Ed Engl. 2006 May 12;45(20):3216-51
references.pmid: 16676373
references.citation: Angew Chem Int Ed Engl. 2004 Dec 27;44(2):288-92
references.pmid: 15614899
references.citation: Chem Commun (Camb). 2011 Sep 28;47(36):9972-85
references.pmid: 21716992
references.citation: J Occup Environ Med. 2003 Apr;45(4):400-9
references.pmid: 12708144
references.citation: J Control Release. 2002 Dec 5;84(3):137-50
references.pmid: 12468217
references.citation: J Pharm Sci. 1986 Apr;75(4):356-60
references.pmid: 2941563
references.citation: J Colloid Interface Sci. 2009 Dec 15;340(2):202-8
references.pmid: 19783256
references.citation: Curr Opin Chem Biol. 2005 Dec;9(6):674-9
references.pmid: 16233988
references.citation: Curr Opin Clin Nutr Metab Care. 2012 Jan;15(1):1-6
references.pmid: 22108093
references.citation: Int J Pharm. 2012 Feb 28;423(2):509-15
references.pmid: 22178618
references.citation: Interface Focus. 2012 Jun 6;2(3):292-306
references.pmid: 23741607
references.citation: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Sep-Oct;1(5):502-10
references.pmid: 20049813
references.citation: ACS Nano. 2011 Feb 22;5(2):1259-66
references.pmid: 21250653
references.citation: Angew Chem Int Ed Engl. 2010 Oct 25;49(44):8214-9
references.pmid: 20865709
references.citation: Materials (Basel). 2012 Feb 21;5(2):350-363
references.pmid: 28817050